Talk:Herpes: Difference between revisions
imported>Nancy Sculerati (References - with notes) |
imported>Nancy Sculerati No edit summary |
||
| Line 5: | Line 5: | ||
"This article reviews the 2006 releases from the Centers for Disease Control and Prevention (CDC) regarding the 2004 National Surveillance Data for sexually transmitted diseases (STDs), the 2006 STDs Treatment Guidelines, the new developments in testing for genital herpes virus (HSV) and human papillomavirus (HPV), and the recent recommendations for the HPV vaccine." | "This article reviews the 2006 releases from the Centers for Disease Control and Prevention (CDC) regarding the 2004 National Surveillance Data for sexually transmitted diseases (STDs), the 2006 STDs Treatment Guidelines, the new developments in testing for genital herpes virus (HSV) and human papillomavirus (HPV), and the recent recommendations for the HPV vaccine." | ||
"With 50 million persons in the United States infected, the herpes simplex virus type 2 (HSV-2) is the most prevalent STD. However, the majority of infected persons are unaware or have not been diagnosed. Patients transmit HSV when symptomatic lesions are present or during episodes of asymptomatic viral shedding. Consequently, approximately one million people acquire HSV-2 each year." | "With 50 million persons in the United States infected, the herpes simplex virus type 2 (HSV-2) is the most prevalent STD. However, the majority of infected persons are unaware or have not been diagnosed. Patients transmit HSV when symptomatic lesions are present or during episodes of asymptomatic viral shedding. Consequently, approximately one million people acquire HSV-2 each year." | ||
==neonatal== | |||
Tita AT. Grobman WA. Rouse DJ. Antenatal herpes serologic screening: an appraisal of the evidence. [Review] [49 refs] Obstetrics & Gynecology. 108(5):1247-53, 2006 Nov. UI: 17077252 | |||
Revision as of 10:38, 4 May 2007
References - with notes
Kirkland LG. New developments in the management of STDs. [Review] [10 refs] [Journal Article. Review] Nurse Practitioner. 31(12):12-21; quiz 22-3, 2006 Dec. UI: 17149130 "This article reviews the 2006 releases from the Centers for Disease Control and Prevention (CDC) regarding the 2004 National Surveillance Data for sexually transmitted diseases (STDs), the 2006 STDs Treatment Guidelines, the new developments in testing for genital herpes virus (HSV) and human papillomavirus (HPV), and the recent recommendations for the HPV vaccine." "With 50 million persons in the United States infected, the herpes simplex virus type 2 (HSV-2) is the most prevalent STD. However, the majority of infected persons are unaware or have not been diagnosed. Patients transmit HSV when symptomatic lesions are present or during episodes of asymptomatic viral shedding. Consequently, approximately one million people acquire HSV-2 each year."
neonatal
Tita AT. Grobman WA. Rouse DJ. Antenatal herpes serologic screening: an appraisal of the evidence. [Review] [49 refs] Obstetrics & Gynecology. 108(5):1247-53, 2006 Nov. UI: 17077252